EPTOMENINGEAL dissemination of cancer has been thought to be a rare antemortem finding, 15 given that most cases are diagnosed at autopsy. As a result, the condition has been mentioned in only a few case reports. During the past few decades, however, LMD has been diagnosed more frequently because of several factors, 3, 15, 25 including the new neuroimaging methodology with improved sensitivity in detecting the disease; physicians' increased awareness of, and readiness to undertake, lumbar spinal tap with CSF cytological evaluation; and the increased efficacy of systemic cancer treatment modalities. Such advancements have afforded prolonged survival in patients, and therefore, the opportunity for LMD symptoms to become clinically apparent.
erature suggests the need for further evidence. In a large sample, we tested the hypothesis that among patients with MPFLs, those initially treated with resection have a higher risk of LMD than those initially treated with SRS.
Clinical Material and Methods

Patient Population
This study was approved by the institutional review board at The University of Texas M. D. Anderson Cancer Center. In our multidisciplinary Brain and Spine Center database, we identified 481 patients with MPFLs who had been treated using either resection or SRS between 1993 and 2004. Patients were excluded if they had undergone resection or SRS for an MPFL or had LMD prior to the index procedure. They were also excluded if they had no follow-up at the Brain and Spine Center after the index procedure. Patients were not excluded if they had received WBRT or if their supratentorial lesion(s) had been resected and/or they had undergone SRS. Of the 481 patients, 379 fulfilled the eligibility criteria and were included in this report.
The following data were collected when available: patient age; sex; KPS score; Radiation Therapy Oncology Group RPA grade; 11 time from the primary cancer diagnosis to the diagnosis of a metastatic brain lesion and to the index procedure; primary tumor site, histological features, and activity (no evidence of, stable, or progressing disease); presence of other noncerebral metastatic sites; previous CNS treatment; number of metastatic brain lesions (all CNS locations; all MPFLs and those treated with the index procedure); location of the treated MPFL; method of resection (en bloc or piecemeal; in patients with Ͼ 1 MPFL at the time of the index surgery, all of the MPFLs had to have been resected en bloc for the index procedure to be categorized in the en bloc treatment group); extent of resection; type of index procedure (resection or SRS); number, location, and treatment of CNS recurrences after the index procedure; radiological or cytological evidence of LMD and date of diagnosis; and duration of follow-up. The method of resection was prospectively noted by the neurosurgeons and entered into the database at the time of the procedure. Our primary outcome was the incidence of LMD as diagnosed with cytological CSF analysis or typical neuroimaging findings such as leptomeningeal enhancement extending into cerebral sulci or spinal intradural extramedullary tumor deposits. 10 Patients were tracked in the standard posttreatment fashion with neuroimaging every 4 to 12 weeks, depending on the clinical scenario, until the patients died or no longer returned to M. D. Anderson (that is, due to a change in the treatment locale, referral to hospice care, or loss to follow-up).
In patients treated with resection, we determined whether the location of the tumor relative to eloquent brain (tumor functional grade), lesion size, or cystic/necrotic appearance of the lesion caused a surgical bias toward en bloc or piecemeal resection, potentially influencing the incidence of LMD, and we noted the incidence of complications occurring within 30 days of the procedure in the 2 resection groups. Complications were classified as "any" or "neurological."
Statistical Analysis
Frequencies and descriptive statistics on the various entities under study were calculated. The differences in the distribution of discrete characteristics between the resection and SRS groups as well as the LMD and no-LMD groups were analyzed using the chi-square test or the Fisher exact test, as appropriate. Continuous and ordinal variables were analyzed using the Student t-test or a nonparametric test, as appropriate.
In determining the incidence of LMD, patients were censored at the time of an MPFL-directed excision or SRS that followed the index procedure. The cumulative proportions of LMD (overall, in the resection group, and in the SRS group) and their 95% CIs, adjusted for a competing death event, were obtained using the cumulative incidence method of Prentice et al. 30 The Cox proportional hazards method was used to estimate the crude rate of LMD following resection (overall, en bloc, and piecemeal) compared with that after SRS and to compute the rate adjusted for other covariates. The 95% CIs for these rates were also obtained. Significant predictors of LMD were determined using a stepwise backward Cox proportional hazards model. A probability value Յ 0.05 was considered statistically significant. The hazard rate for survival after LMD diagnosis was determined using a Cox proportional hazards model, with LMD considered as a time-dependent covariate.
Results
Detailed patient characteristics (overall and according to treatment group) are presented in Table 1 . Among the 379 patients included in this report, 194 (51%) were male and 185 (49%) were female. The median patient age at the time of the index procedure was 56 years (range 8-91 years). Most patients had a high performance status, as evidenced by a KPS score Ն 70 in 93% of them. The most common primary tumor treated was lung cancer (35%) followed by breast cancer (19%), melanoma (14%), renal cancer (12%), genitourinary cancer (6%), colorectal cancer (4%), and other (10%). Among the patients treated with resection, 123 (47%) underwent an en bloc procedure and 137 (53%), a piecemeal procedure (7 of these had Ͼ 1 MPFL, Ն 1 of which was extirpated in piecemeal fashion). Gross-total resection (defined as the removal of Ն 95% of the tumor) was achieved in 96% of the cases. There were no statistically significant differences between the resection and SRS groups regarding the duration of clinical follow-up (3.2 and 4.9 months, respectively) or vital status follow-up (medians of 14.5 and 7.7 months, respectively, among the 62 patients alive at the end of follow-up).
Among the 379 patients, 260 underwent tumor resection, whereas 119 had SRS. Notably, the resection group contained of a larger proportion of patients with newly diagnosed, previously untreated metastatic brain lesions (82% compared with 44% in the SRS group, p Ͻ 0.001). This finding was paralleled by a smaller proportion of patients with previous craniotomy, chemotherapy, and radiation; a shorter median interval from the initial establishment of a brain cancer diagnosis to the index procedure (resection: 0.5 months [range 0.0-23.2 months], SRS: 2.9 months [range 0.0-59.3 months]; p Ͻ 0.001); and a smaller proportion of systemic noncerebral metastases at the time of the index procedure (resection: 44%, SRS: 64%; p Ͻ 0.001). On the other hand, patients who underwent SRS were more likely to have 1 MPFL (90%) than were those who underwent resection (76%; p = 0.002); these patients were also more likely to have lesions outside the cerebellum (35 and 9%, respectively; p Ͻ 0.001).
Leptomeningeal disease occurred in 33 of the 379 patients. The median time to LMD among these 33 patients was 3.7 months (range Ͻ 1-13.1 months). The cumulative proportion of LMD in the overall group, adjusted for a competing death event, was 19% (95% CI 13-26%). All 33 patients with a diagnosis of LMD after the index procedure had neuroimaging and/or CSF evidence of the disease. No patient was included as an LMD case based purely on the grounds of clinical examination. All 33 patients underwent neuroimaging, and 85% of them (95% CI 68-95%) had positive LMD findings. Among the 21 patients who had undergone a CSF analysis, 16 (76%, 95% CI 53-92%) had findings positive for LMD. Eleven patients had evidence of LMD according to both imaging studies and cytological analysis, whereas in 10 patients imaging and cytological data were discordant. The distribution of LMD cases among the various primary cancers is presented in Table  2 . Notably, LMD developed in 2 of 6 patients with a primary gastrointestinal tumor. Counterintuitively, the incidence of LMD was higher in patients whose systemic disease (primary and extracerebral metastases) was controlled (23 [13%] of 182 patients) than in those whose disease was progressing at the time of the index procedure (10 [6%] of 181 patients; p = 0.02). Still, most of the patients in whom LMD developed (67%) had systemic cancer dissemination at the time of LMD diagnosis. Leptomeningeal disease was diagnosed in 21 patients (64%) as the only site of initial brain recurrence. The other 12 patients had local or distant brain recurrences diagnosed before or at the same time as the LMD; in these patients, recurrent MPFLs were not treated with resection or SRS prior to the LMD diagnosis.
The roles of resection and SRS as predictors of LMD occurrence were evaluated. Leptomeningeal disease occurred in 26 of the 260 patients who had undergone resection and 7 of the 119 who had undergone SRS. In the resection group, the incidence of LMD was higher in patients whose systemic disease (primary and extracerebral metastases) was controlled (13%) than in those whose disease was progressing at the time of the index procedure (5%; p = 0.03). In contrast, the incidence of LMD was the same (6%) in the SRS group, regardless of whether the systemic disease was controlled or progressing (p = 1.00). Yet, when the LMD diagnosis was established, similar proportions of patients who had undergone resection and SRS (64 and 71%, respectively) had systemic cancer dissemination, and similar proportions (38 and 29%; p = 1.00) had other sites of tumor recurrence in the brain.
The respective cumulative proportions of LMD and the accompanying 95% CIs, adjusted for competing death events, were 22% (95% CI 15-33%) in the resection group and 18% (95% CI 9-38%) in the SRS group. The crude RR for LMD in the resection group was 2.06 (95% CI 0.89-4.75, p = 0.09; Table 2 ). When adjusted for all other covariates in the multivariate Cox proportional hazards model, the RR and significance were consistent with no effect (RR 1.08, 95% CI 0.37-3.17, p = 0.89).
The difference in the characteristics of patients between the 2 groups, especially the higher prevalence of newly diagnosed disease in the resection group and the greater frequency of MPFLs in the SRS group, raised the concern of a selection bias. To minimize the risk of a spurious conclusion, we repeated our analyses in the subgroup of patients with newly diagnosed brain cancer who had only 1 MPFL. In this subgroup of 213 patients, 163 underwent resection and 50 received SRS. The cumulative proportions of LMD were 21% (95% CI 13-33%) and 16% (95% CI 5-54%) for the resection and SRS groups, respectively. The RR for resection in this selected subset of patients was consistent with the ratio for the whole group (RR 3.25, 95% CI 0.75-14.10, p = 0.12). Further exclusion of patients with any supratentorial tumor at the time of the index procedure (134 patients: 107 in the resection group and 27 in the SRS group) also produced consistent results (resection: RR 2.39, 95% CI 0.54-10.55, p = 0.25).
Among the patients who underwent resection, the method was significantly associated with the incidence of LMD (7 of 123 cases for en bloc procedures and 19 of 137 cases for piecemeal procedures; Fig. 1 ). We compared the incidence of LMD among patients in whom MPFLs had been treated using SRS (119 patients) with its incidence in those in whom the MPFLs were resected via an en bloc resection (123 patients) and then in those whose lesion was resected piecemeal (137 patients). Although no significant difference or trend for a difference was found between the SRS and en bloc groups (en bloc: RR 0.98, 95% CI 0.34-2.81, p = 0.98), the RR for the piecemeal resection group was 3.37 (95% CI 1.41-8.04, p = 0.006), indicating a strong increased risk. When adjusted for other covariates in a backward stepwise multivariate Cox proportional hazards model, the RR and significance for piecemeal resection compared with en bloc removal and SRS were consistent, with a significant strong effect (RR 2.45, 95% CI 1.19-5.02, p = 0.02; Fig. 2 ). This finding was noted despite significantly longer durations of clinical follow-up in the en bloc and SRS groups (medians 4.5 and 4.9 months, respectively) than in the piecemeal group (median 2.4 months).
Except for tumors from primary renal cell carcinoma, which were resected via the en bloc approach in 77% of cases, the distributions of piecemeal resections were statistically comparable for other tumor types and ranged from 45% for breast primaries to 72% for colorectal primaries.
Among the various primary cancers, melanomas contributed 24% of the LMD cases, and the incidence of LMD in patients with melanoma was 15%. The largest proportion of LMD cases (36%) involved primary lung cancer. Primary breast cancer ranked third, with 18% of the cases. Primary gastrointestinal cancer contributed 6% of the 33 cases of LMD, but the incidence of LMD in this cancer subgroup was the highest (2 [33%] of 6 cases; adjusted RR 5.6, 95% CI 1.29-24.66). The number of MPFLs was also a significant independent predictor of LMD (RR adjusted for Ͼ 2 MPFLs 3.29, 95% CI 1.24-8.72, p = 0.05).
Patients survived for a median of 2.8 months after the diagnosis of LMD (95% CI 0.6-5.0 months). We evaluated LMD prognosis and found that patients with this condition had a significantly shorter survival time, both clinically and statistically, compared with those without the disease (adjusted RR 3.01, 95% CI 2.05-4.44).
We analyzed the resection method relative to whether the tumor was necrotic or cystic and relative to the tumor functional grade (Table 3) . 34 No bias was seen toward piecemeal (18) 26 (22) 26 (21) 21 (15) melanoma 52 (14) 34 (13) 18 (15) 13 (11) 21 (15) kidney 46 (12) 30 (12) 16 (13) 23 (19) 7 (5) genitourinary 24 (6) 19 (7) 5 (4) 9 (7) 10 (7) colorectal 17 (4) 14 (5) 3 (2) 4 (3) 10 (7) (8) 26 (10) 6 (5) 13 (10) 13 (10) ; p Ͻ 0.001 for all paired comparisons). The effect of the treatment method on the risk of LMD was consistent regardless of tumor volume.
The incidence of postoperative complications, neurological or otherwise, was similar for patients with tumors removed en bloc or piecemeal (Table 4) .
Discussion
Many published reports document a higher incidence of LMD among patients with solid tumor metastases to the posterior fossa than in those with supratentorial lesions. 6, 7, 17, 21, 24, 35, 39 In one study of patients treated surgically and nonsurgically, estimates of the LMD incidence were 15% in the presence of an MPFL and 10% in the presence of a supratentorial metastasis. 35 Respective estimates of spinal LMD in 2 studies with patients treated with resection or nonsurgically were 10 to 11% 20, 21 and 0%. 21 Among surgical patients, estimates of LMD have ranged from 25 to 67% when an MPFL was present compared with 0 to 17% with supratentorial metastases. 6, 7, 17, 24, 39 Authors of more recent studies have particularly incriminated surgery for MPFLs in facilitating LMD. The intraoperative tumor spill mechanism is well recognized in cancer patients 9, 23, 24 and holds true during resection of intraparenchymal metastases. 9, 24, 27, 33, 39 In particular, the slow CSF flow in the posterior fossa region of the brain, which promotes the deposition of circulating cells, and the more intimate contact with the subarachnoid space and cisterna magna in this area, which may offer a nidus for tumor cells, 6, 15, 24, 39 could increase the risk of LMD after the resection of tumors in this region. Conversely, the absence of such a CSF-containing space over the hemispheres might explain the low incidence of LMD in the case of a supratentorial lesion. There is no formal estimate of the minimum number of tumor cells in the CSF that would be sufficient to cause LMD. 24 Extrapolating from animal models, in which the introduction of 3000 tumor cells has resulted in rapid death from LMD, 28 the number is likely to be very small.
Additional observations incriminating surgery include the development of LMD promptly after surgery (1-7 months) 17, 24 and its more frequent occurrence in individuals with no systemic dissemination. 6, 24, 39 The leptomeninges was the only site of recurrence in 5 of 9 patients included in the van der Ree et al. 39 study and 3 of 4 patients with cerebellar metastasis in the Norris et al. 24 report. Similarly, in the DeAngelis and colleagues 6 study, the condition developed significantly more often in patients with no evidence of systemic disease (16%) and in those with local disease (9%) than in those with disseminated disease (0%; p = 0.019). These observations do not follow the accepted notion that LMD develops late in the disease course in patients with widely metastasized cancers, 15, 39, 40 supporting instead the presence of a contributing effect of surgery. In the current study, the median time to LMD development was 3.7 months (range Ͻ 1-13.1 months). Moreover, at the time of LMD diagnosis, the leptomeninges was the only site of recurrence in 16 patients (62%) who underwent resection. The other resection patients had local or distant CNS tumor recurrence either before or at the same time as the diagnosis of LMD. As in the DeAngelis et al. 6 study, LMD developed more frequently in patients who, at the time of resection, had no evidence of or stable disease (13%) rather than progressive or disseminated disease (5%; p = 0.03). However, at the time the LMD diagnosis was established, almost two thirds (64%) of the patients in the resection group had extracerebral disseminated disease, a proportion similar to that in the SRS group (71%). Moreover, the proportion of SRS-treated patients who had no other site of recurrence in the brain (71%) was also similar to that in the resection group (p = 1.00).
A major limitation of the previously described studies is the lack of a nonsurgical comparison group 6, 17, 24, 39 or the absence of details on any subgroup analysis among surgical and nonsurgical patients. 20 , 21 Mahajan and colleagues 19 reviewed data on 101 patients treated with Gamma Knife surgery for intracranial metastases from any site and reported a higher incidence of LMD in patients in whom surgery had been performed and the interval between surgery and Gamma Knife surgery had been prolonged beyond 30 days. In that study, however, faulty statistical methodology was used to estimate incidence and survival differences between the surgical and nonsurgical groups. Moreover, the study was not designed a priori to establish an effect of surgery on the incidence of LMD. Patients treated with surgery but without subsequent radiosurgery were not included-an exclusion that potentially introduces a selection bias against the surgery group. The authors also did not specifically address metastases in the posterior fossa area. A comparison of the effects of surgery and radiosurgery in patients with MPFLs was recently performed by Siomin and associates. 37 The authors retrospectively reviewed the charts of 80 eligible and evaluable cancer patients treated with neurosurgery (18 patients) or SRS (62 patients) at the Cleveland Clinic between 1995 and 2001. Leptomeningeal disease occurred in 9 surgical patients (50%), but only 4 (6.5%) of the 62 patients treated with SRS. These proportions were statistically significant. The duration of the follow-up was reported to vary from 1.0 to 81.8 months from the time of metastasis to the brain and from 1 to 60 months for those alive at the time of the analysis. The authors used simple proportions and a logistic regression analysis to determine the incidence and predictors of LMD, respectively, in a population with a wide range of follow-up times. Although the authors state that patients with evidence of LMD at the time of treatment were excluded, surgical patients in their study were generally more symptomatic than nonsurgical patients and showed a trend toward a ‡ Referent: the group with which all others are compared. § Data were unavailable in some patients. || Each primary lesion type was compared with all other types in the same category. ** Includes larynx (4), bone (3), parotid gland (2), supraglottic (2), soft palate (1), forearm (1), mediastinum (1), head and neck (1).
poorer performance status at presentation for the index procedure. In the present study, the proportions of patients presenting with a poor performance status (KPS score Ͻ 70) were not significantly different in the 2 groups (8% in the resection group and 4% in the SRS group; p = 0.20). The resection group did not have a significantly higher incidence of LMD despite a higher proportion of patients presenting with symptoms in that group (85%) than in the SRS group (53%; p Ͻ 0.001).
We failed to show a significant effect of resection in general on the incidence of LMD, according to both univariate and multivariate analyses. The tendency for such an increased risk was small and not as alarming as reported by Siomin et al. 37 This finding remained unchanged when the comparisons were made in the more homogeneous groups of patients with previously untreated metastasis to the brain and those with 1 MPFL, with or without supratentorial lesions.
Underdiagnosis as an alternative explanation for the lower overall frequency of LMD in our study is unlikely. Physicians at M. D. Anderson are very thorough, and the likelihood that presenting symptoms could have been missed is minimal. Moreover, the methods used to diagnose LMD are highly sensitive if not definitive. A strong adherence of malignant cells to the leptomeninges 40 or the presence of a focal rather than widespread leptomeningeal tumor, 13 among other things, can contribute to false-negative cytological results in one third to one half of patients. However, a rigorous methodology including the withdrawal of Ն 10.5 ml of CSF for cytological analysis and CSF close to the site of symptomatic disease as well as at multiple locations along the neuraxis (for example, cisternal puncture), the delivery of CSF for immediate processing, and the performance of serial punctures 12, 13, 31, 40 can increase the sensitivity of the test up to 90 to 100%. Such measures are indeed followed at M. D. Anderson. Although 17 patients had only a neuroimaging-based diagnosis of LMD (5 with a negative CSF finding and 12 in whom CSF testing was not performed), we do not question the adequacy of the diagnosis, as magnetic resonance imaging showed typical abnormalities according to the criteria proposed by Freilich et al. 10 Such criteria have confirmed and even established the diagnosis of LMD in a convincing fashion in a patient with a known systemic solid cancer, who was believed to have LMD, that is, who presented with clinical features typical of the disease. 10 Excluding patients with no cytological evidence of LMD does not alter the comparative incidence of the condition between the resection and SRS groups.
Despite overall short clinical follow-ups in the present study, the resection and SRS groups had statistically similar durations of follow-up, which minimizes the likelihood that this factor differentially affected the ascertainment of LMD incidence. Leptomeningeal disease occurred early in many of the studies mentioned previously 17, 24 as well as in the analysis by van der Ree et al. 39 No such comparative data are presented in the Siomin et al. paper. 37 Alternatively, there are a number of processes that mimic LMD, including neurosarcoidosis, chronic meningitis, and Guillain-Barré syndrome.
14 Linear vascular enhancement, particularly of the cauda equina, can mimic pathological enhancement of the roots and lead to an inaccurate diagnosis. In addition, lumbar puncture can induce a meningeal reaction that appears as leptomeningeal enhancement on Gd-enhanced images. 22, 26 Such enhancement can persist for weeks to months, and in some patients can even be accompanied by a low-pressure headache syndrome. Similar processes could explain the high incidence of LMD in the Siomin et al. study. 37 The typically late occurrence of LMD noted by these authors strengthens the likelihood of a misdiagnosis in at least some of the patients, as any increased incidence of LMD owing to surgery presumably would have manifested as an early postoperative diagnosis of LMD. Death in patients soon after the diagnosis of the true condition may have resulted from various other causes during this late stage of the disease.
We further analyzed the issue of the intraoperative spillage of tumor cells by incorporating data on the resection methodology (en bloc or piecemeal). Such data were re- corded prospectively by the neurosurgeons on completion of the surgery. In a study by Salvati et al. 33 of 19 patients with solitary metastasis from melanoma surgically treated between 1952 and 1990, no relapses in the brain were observed in the 9 patients treated using en bloc removal compared with 5 patients (50%) in whom en bloc removal was not achieved (p = 0.06). There was no reference to surgical methodology (en bloc or piecemeal) in the paper by Siomin et al. 37 The large proportion of piecemeal resections in that series could also explain, to some extent, the higher observed incidence of LMD. In our series, 123 patients underwent en bloc resection of all treated MPFLs, and 137 underwent piecemeal resection of Ն 1 MPFL. The latter technique was significantly associated with an increased incidence of LMD. A comparison of the piecemeal resection and SRS-treated groups revealed a 3-fold increased rate of LMD with the former method on univariate analysis and a 2-fold increased rate of LMD on multivariate analysis, after correction for other risk factors. This association was observed despite a significantly shorter duration of follow-up in the piecemeal resection group compared with the en bloc and SRS groups.
We looked for a confounding effect of tumor histological characteristics, functional grade, and size and the cystic or necrotic appearance of the tumor on the above relationship (that is, between the method of treatment and the incidence of LMD). Whereas the majority of lesions from primary renal cancers were resected using the en bloc procedure (77%), the distribution of piecemeal or en bloc resection was not significantly different among breast, lung, colorectal, or gastrointestinal cancers or melanoma. Likewise, the distribution of en bloc or piecemeal resection was not significantly different for tumors having a cystic or necrotic appearance or for lesions of different functional grades. On the other hand, tumor size was significantly different among the 3 treatment groups, but the effect was consistent regardless of tumor size. Notably, despite the significant difference in tumor volume between the SRS and en bloc resection groups in this study, the incidence of LMD between the 2 arms was comparable.
Leptomeningeal disease has a poor prognosis. 8, 15, 16, 20, 24, 35 In this study, patients with LMD had a significantly shorter survival interval, both clinically and statistically, than those without LMD (adjusted RR 3.01, 95% CI 2.05-4.44).
In view of the poor prognosis, physicians should be alerted to the higher risk of LMD after piecemeal resection and should take appropriate early measures to prevent or treat it. Intrathecal chemotherapy or radiation therapy after MPFL surgery could help prevent viable tumor cells from disseminating throughout the neuraxis and prevent LMD from occurring. Early diagnosis is important given that recent data suggest that after the prompt initiation of treatment, especially in patients with good performance status and neurological function, a low subarachnoid tumor burden is likely to prolong survival. 5 In the literature, LMD is most likely to occur in patients with melanoma (23-25%), 1, 37 followed by those with lung cancer (9-25%) 2,32,37 and breast cancer (5%), 41 although Siomin et al. 37 noted an LMD incidence of 25% among 16 patients with the latter pathological entity. Given the incidence of cancer at these sites, most studies on LMD have a large proportion of breast and lung cancer cases (11-64% and 14-46% of cases, respectively), followed by melanoma (3.5-18%). 4, 8, 13, 18, [36] [37] [38] 40 Our results generally supported these findings. Patients with melanoma were prone to LMD, although the incidence was limited to 15%. A melanoma primary contributed 24% of the LMD cases, a proportion somewhat higher than reported in other studies, probably reflecting the referral pattern at M. D. Anderson. The largest proportion of patients with LMD (36%) had a lung primary. Breast primaries ranked third, with 18% of the cases. Of interest in our study are the gastrointestinal primaries. Although they contributed only 6% of the 33 LMD cases, the incidence of LMD in this cancer subgroup was the highest (2 [33%] of 6 cases), a finding supported on multivariate analysis. The number of MPFLs was also a significant independent predictor of LMD.
Conclusions
There is an increased risk of LMD after the resection of a posterior fossa solid tumor metastasis in cases in which a tumor is removed via a piecemeal approach. This difference, although clinically and statistically significant, is not as alarming as previously described and is not apparent when en bloc resection is achieved. Further assessment of the role of surgery in a controlled prospective setting is warranted. 
